Prevalence of Confirmed Vs. Declared Beta-Lactam Allergies in Patients
JUN 12, 2017 | CONTAGION® EDITORIAL STAFF
Davey Legendre, PharmD, MBA, BCPS, Region Vice President, Clinical Infectious Diseases, Comprehensive Pharmacy Services, sheds light on the prevalence of confirmed beta-lactam allergies in patients.
Interview Transcript (slightly modified for readability)
“The prevalence of confirmed beta-lactam allergy in patients is somewhere around 1% to 10% of patients that actually present to the hospital and declare an allergy. Up to 20% of patients actually declare an antibiotic allergy at some point during their stay, but only a fraction of those patients have a confirmed beta-lactam allergy.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512